Application of microRNAs in diabetes mellitus

Journal of Endocrinology

Volumn 222, Issue 1, 2014, Pages

  Chen, Haiyong ^a   Lan, Hui Yao ^b   Roukos, Dimitrios H ^c   Cho, William C ^d  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Chinese University of Hong Kong   (Hong Kong)

^c UNIVERSITY OF IOANNINA   (Greece)

^d QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Diabetes; Insulin resistance; Microrna; T1D; T2D

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTISENSE OLIGONUCLEOTIDE; GLUCOSE TRANSPORTER 4; INSULIN; MICRORNA; MICRORNA 103; MICRORNA 107; MICRORNA 122; MICRORNA 126; MICRORNA 143; MICRORNA 181A; MICRORNA 221; MICRORNA 223; MICRORNA 29; MICRORNA 320; MICRORNA 375; MICRORNA 494; MICRORNA 802; MICRORNA 9; MICRORNA 93; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE 1B; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; CELL FATE; DIABETES MELLITUS; EXCITABILITY; EXOCYTOSIS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

DIABETES; INSULIN RESISTANCE; MICRORNA; T1D; T2D;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; MICRORNAS;

EID: 84904440080     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0544     Document Type: Review

References (78)

1. American Diabetes Association 2013 Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36 1033-1046. (doi:10.2337/dc12-2625)
2. Aronovich EL, McIvor RS & Hackett PB 2011 The sleeping beauty transposon system: a non-viral vector for gene therapy. Human Molecular Genetics 20 R14-R20. (doi:10.1093/hmg/ddr140)
3. Baroukh N, Ravier MA, Loder MK, Hill EV, Bounacer A, Scharfmann R, Rutter GA & Van Obberghen E 2007 MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic b-cell lines. Journal of Biological Chemistry 282 19575-19588. (doi:10.1074/jbc. M611841200)
4. Bartel DP 2004 MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 281-297. (doi:10.1016/S0092-8674(04)00045-5)
5. Bordone L, Motta MC, Picard F, Robinson A, Jhala US, Apfeld J, McDonagh T, Lemieux M, McBurney M, Szilvasi A et al. 2006 Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic b cells. PLoS Biology 4 e31. (doi:10.1371/journal.pbio.0040031)
6. Chen HY, Huang XR, Wang W, Li JH, Heuchel RL, Chung AC & Lan HY 2011 The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes 60 590-601. (doi:10.2337/db10-0403)
7. Chen YH, Heneidi S, Lee JM, Layman LC, Stepp DW, Gamboa GM, Chen BS, Chazenbalk G & Azziz R 2013 miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes 62 2278-2286. (doi:10. 2337/db12-0963)
8. Chen HY, Zhong X, Huang XR, Meng XM, You Y, Chung AC & Lan HY 2014 MicroRNA-29b inhibits diabetic nephropathy in db/db mice. Molecular Therapy 22 842-853. (doi:10.1038/mt.2013.235)
9. Czech MP, Aouadi M & Tesz GJ 2011 RNAi-based therapeutic strategies for metabolic disease. Nature Reviews. Endocrinology 7 473-484. (doi:10.1038/nrendo.2011.57)
10. Dou L, Zhao T, Wang L, Huang X, Jiao J, Gao D, Zhang H, Shen T, Man Y, Wang S et al. 2013 miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes. Journal of Biological Chemistry 288 22596-22606. (doi:10.1074/jbc. M112.423145)
11. El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D & van Obberghen E 2008 miR-375 targets 30-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic b-cells. Diabetes 57 2708-2717. (doi:10.2337/db07-1614)
12. Erener S, Mojibian M, Fox JK, Denroche HC & Kieffer TJ 2013 Circulating miR-375 as a biomarker of b-cell death and diabetes in mice. Endocrinology 154 603-608. (doi:10.1210/en.2012-1744)
13. Fernandez-Valverde SL, Taft RJ & Mattick JS 2011 MicroRNAs in b-cell biology, insulin resistance, diabetes and its complications. Diabetes 60 1825-1831. (doi:10.2337/db11-0171)
14. Fowler MJ 2008 Microvascular and macrovascular complications of diabetes. Clinical Diabetes 26 77-82. (doi:10.2337/diaclin.26.2.77)
15. Frost RJ & Olson EN 2011 Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. PNAS 108 21075-21080. (doi:10.1073/pnas.1118922109)
16. Guay C & Regazzi R 2013 Circulating microRNAs as novel biomarkers for diabetes mellitus. Nature Reviews. Endocrinology 9 513-521. (doi:10.1038/nrendo.2013.86)
17. Guay C, Roggli E, Nesca V, Jacovetti C & Regazzi R 2011 Diabetes mellitus, a microRNA-related disease? Translational Research 157 253-264. (doi:10.1016/j.trsl.2011.01.009)
18. Hashimoto N, Kido Y, Uchida T, Asahara S, Shigeyama Y, Matsuda T, Takeda A, Tsuchihashi D, Nishizawa A, OgawaWet al. 2006 Ablation of PDK1 in pancreatic b cells induces diabetes as a result of loss of b cell mass. Nature Genetics 38 589-593. (doi:10.1038/ng1774)
19. He A, Zhu L, Gupta N, Chang Y & Fang F 2007 Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Molecular Endocrinology 21 2785-2794. (doi:10.1210/me.2007-0167)
20. Herrera BM, Lockstone HE, Taylor JM, Wills QF, Kaisaki PJ, Barrett A, Camps C, Fernandez C, Ragoussis J, Gauguier D et al. 2009 MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of type 2 diabetes. BMC Medical Genomics 2 54. (doi:10.1186/1755-8794-2-54)
21. Herrera BM, Lockstone HE, Taylor JM, Ria M, Barrett A, Collins S, Kaisaki P, Argoud K, Fernandez C, Travers ME et al. 2010 Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 53 1099-1109. (doi:10.1007/s00125-010-1667-2)
22. Huang B, Qin W, Zhao B, Shi Y, Yao C, Li J, Xiao H & Jin Y 2009 MicroRNA expression profiling in diabetic GK rat model. Acta Biochimica et Biophysica Sinica 41 472-477. (doi:10.1093/abbs/gmp035)
23. Jeong HJ, Park SY, Yang WM & Lee W 2013 The induction of miR-96 by mitochondrial dysfunction causes impaired glycogen synthesis through translational repression of IRS-1 in SK-Hep1 cells. Biochemical and Biophysical Research Communications 434 503-508. (doi:10.1016/j.bbrc.2013.03.104)
24. Jia W & Zhou Q 2005 Viral vectors for cancer gene therapy: viral dissemination and tumor targeting. Current Gene Therapy 5 133-142. (doi:10.2174/1566523052997460)
25. Jordan SD, Kruger M, Willmes DM, Redemann N, Wunderlich FT, Bronneke HS, Merkwirth C, Kashkar H, Olkkonen VM, Bottger T et al. 2011 Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nature Cell Biology 13 434-446. (doi:10.1038/ncb2211)
26. Joven J, Espinel E, Rull A, Aragones G, Rodriguez-Gallego E, Camps J, Micol V, Herranz-Lopez M, Menendez JA, Borras I et al. 2012 Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice. Biochimica et Biophysica Acta 1820 894-899. (doi:10.1016/j.bbagen.2012.03.020)
27. Karolina DS, Armugam A, Tavintharan S, Wong MT, Lim SC, Sum CF & Jeyaseelan K 2011 MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS ONE 6 e22839. (doi:10.1371/journal.pone. 0022839)
28. Katta A, Thulluri S, Manne ND, Addagarla HS, Arvapalli R, Nalabotu SK, Gadde M, Rice KM & Blough ER 2013 Overload induced heat shock proteins (HSPs), MAPK and miRNA (miR-1 and miR133a) response in insulin-resistant skeletal muscle. Cellular Physiology and Biochemistry 31 219-229. (doi:10.1159/000343363)
29. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD & Plasterk RH 2007 Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biology 5 e203. (doi:10.1371/journal.pbio.0050203)
30. Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, Dong Q, Pang Z, Guan Q, Gao L et al. 2011 Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetologia 48 61-69. (doi:10.1007/s00592-010-0226-0)
31. Kornfeld JW, Baitzel C, Konner AC, Nicholls HT, Vogt MC, Herrmanns K, Scheja L, Haumaitre C, Wolf AM, Knippschild U et al. 2013 Obesityinduced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 494 111-115. (doi:10.1038/nature11793)
32. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, Morishita R & Johnson RJ 2003 Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. Journal of the American Society of Nephrology 14 1535-1548. (doi:10.1097/01.ASN.0000067632.04658.B8)
33. Layden BT, Durai V & Lowe WL Jr 2010 G-protein-coupled receptors, pancreatic islets, and diabetes. Nature Education 3 13.
34. Lee H, Jee Y, Hong K, Hwang GS & Chun KH 2013 MicroRNA-494, upregulated by tumor necrosis factor-a, desensitizes insulin effect in C2C12 muscle cells. PLoS ONE 8 e83471. (doi:10.1371/journal.pone. 0083471)
35. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY & Zen K 2010 SerummicroRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Research 70 9798-9807. (doi:10.1158/0008-5472.CAN-10-1001)
36. Ling HY, Ou HS, Feng SD, Zhang XY, Tuo QH, Chen LX, Zhu BY, Gao ZP, Tang CK, Yin WD et al. 2009 Changes in microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clinical and Experimental Pharmacology & Physiology 36 e32-e39. (doi:10.1111/j.1440-1681.2009.05207.x)
37. Ling HY, Hu B, Hu XB, Zhong J, Feng SD, Qin L, Liu G, Wen GB & Liao DF 2012 miRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue. Experimental and Clinical Endocrinology & Diabetes 120 553-559. (doi:10.1055/s-0032-1311644)
38. Lovis P, Gattesco S & Regazzi R 2008a Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biological Chemistry 389 305-312. (doi:10.1515/BC. 2008.026)
39. Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, Abderrahmani A & Regazzi R 2008b Alterations in microRNA expression contribute to fatty acid-induced pancreatic b-cell dysfunction. Diabetes 57 2728-2736. (doi:10.2337/db07-1252)
40. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH & Li Y 2008 MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27 4373-4379. (doi:10.1038/onc.2008.72)
41. Lu H, Buchan RJ & Cook SA 2010 MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovascular Research 86 410-420. (doi:10.1093/cvr/cvq010)
42. Mah C, Byrne BJ & Flotte TR 2002 Virus-based gene delivery systems. Clinical Pharmacokinetics 41 901-911. (doi:10.2165/00003088-200241120-00001)
43. Meerson A, Traurig M, Ossowski V, Fleming JM, Mullins M & Baier LJ 2013 Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-a. Diabetologia 56 1971-1979. (doi:10.1007/s00125-013-2950-9)
44. Merrins MJ & Stuenkel EL 2008 Kinetics of Rab27a-dependent actions on vesicle docking and priming in pancreatic b-cells. Journal of Physiology 586 5367-5381. (doi:10.1113/jphysiol.2008.158477)
45. Nielsen LB, Wang C, Sorensen K, Bang-Berthelsen CH, Hansen L, Andersen ML, Hougaard P, Juul A, Zhang CY, Pociot F et al. 2012 Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual b-cell function and glycaemic control during disease progression. Experimental Diabetes Research 2012 896362. (doi:10.1155/2012/896362)
46. Parra P, Serra F &Palou A 2010 Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS ONE 5 e13005. (doi:10.1371/journal.pone.0013005)
47. Peppa M, Koliaki C, Nikolopoulos P & Raptis SA 2010 Skeletal muscle insulin resistance in endocrine disease. Journal of Biomedicine & Biotechnology 2010 527850. (doi:10.1155/2010/527850)
48. Pescador N, Perez-Barba M, Ibarra JM, Corbaton A, Martinez-Larrad MT & Serrano-Rios M 2013 Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. PLoS ONE 8 e77251. (doi:10.1371/journal.pone.0077251)
49. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F & Regazzi R 2006 MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. Journal of Biological Chemistry 281 26932-26942. (doi:10.1074/jbc. M601225200)
50. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P et al. 2004 A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432 226-230. (doi:10.1038/nature03076)
51. Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P, Zavolan M & Stoffel M 2009 miR-375 maintains normal pancreatic a- and b-cell mass. PNAS 106 5813-5818. (doi:10.1073/pnas. 0810550106)
52. Pullen TJ, da Silva Xavier G, Kelsey G & Rutter GA 2011 miR-29a and miR-29b contribute to pancreatic b-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Molecular and Cellular Biology 31 3182-3194. (doi:10.1128/MCB.01433-10)
53. Ramachandran D, Roy U, Garg S, Ghosh S, Pathak S & Kolthur-Seetharam U 2011 Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic b-islets. FEBS Journal 278 1167-1174. (doi:10.1111/j.1742-4658.2011.08042.x)
54. Roggli E, Britan A, Gattesco S, Lin-Marq N, Abderrahmani A, Meda P & Regazzi R 2010 Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic b-cells. Diabetes 59 978-986. (doi:10.2337/db09-0881)
55. Roggli E, Gattesco S, Caille D, Briet C, Boitard C, Meda P & Regazzi R 2012 Changes in microRNA expression contribute to pancreatic b-cell dysfunction in prediabetic NOD mice. Diabetes 61 1742-1751. (doi:10.2337/db11-1086)
56. Rorsman P & Braun M 2013 Regulation of insulin secretion in human pancreatic islets. Annual Review of Physiology 75 155-179. (doi:10.1146/annurev-physiol-030212-183754)
57. Rottiers V & Naar AM 2012 MicroRNAs in metabolism and metabolic disorders. Nature Reviews. Molecular Cell Biology 13 239-250. (doi:10.1038/nrm3313)
58. Ruan Q, Wang T, Kameswaran V, Wei Q, Johnson DS, Matschinsky F, ShiW & Chen YH 2011 The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic b cell death. PNAS 108 12030-12035. (doi:10.1073/pnas.1101450108)
59. Ryu HS, Park SY, Ma DA, Zhang J & Lee W2011 The induction ofmicroRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes. PLoS ONE 6 e17343. (doi:10.1371/journal.pone.0017343)
60. Salas-Perez F, Codner E, Valencia E, Pizarro C, Carrasco E & Perez-Bravo F 2013 MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes. Immunobiology 218 733-737. (doi:10.1016/j.imbio.2012.08.276)
61. Samuel VT & Shulman GI 2012 Mechanisms for insulin resistance: common threads and missing links. Cell 148 852-871. (doi:10.1016/j.cell.2012.02.017)
62. Sebastiani G, Grieco FA, Spagnuolo I, Galleri L, Cataldo D & Dotta F 2011 Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity. Diabetes/Metabolism Research and Reviews 27 862-866. (doi:10.1002/dmrr.1262)
63. Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ & Liu ZM 2011 MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Research and Clinical Practice 91 94-100. (doi:10.1016/j.diabres.2010.11.006)
64. Takanabe R, Ono K, Abe Y, Takaya T, Horie T, Wada H, Kita T, Satoh N, Shimatsu A & Hasegawa K 2008 Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochemical and Biophysical Research Communications 376 728-732. (doi:10.1016/j.bbrc.2008.09.050)
65. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, Heim MH & Stoffel M 2011 MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474 649-653. (doi:10.1038/nature10112)
66. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW & Jing Q 2010 Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European Heart Journal 31 659-666. (doi:10.1093/eurheartj/ehq013)
67. Wang RH, Kim HS, Xiao CY, Xu XL, Gavrilova O & Deng CX 2011 Hepatic Sirt1 deficiency in mice impairs mTORC2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. Journal of Clinical Investigation 121 4477-4490. (doi:10.1172/JCI46243)
68. Weiler J, Hunziker J & Hall J 2006 Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Therapy 13 496-502. (doi:10.1038/sj.gt.3302654)
69. Williams MD & Mitchell GM 2012 MicroRNAs in insulin resistance and obesity. Experimental Diabetes Research 2012 484696. (doi:10.1155/2012/484696)
70. Xiao J, Meng XM, Huang XR, Chung AC, Feng YL, Hui DS, Yu CM, Sung JJ & Lan HY 2012 miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Molecular Therapy 20 1251-1260. (doi:10.1038/mt. 2012.36)
71. Yang YM, Seo SY, Kim TH & Kim SG 2012 Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid. Hepatology 56 2209-2220. (doi:10.1002/hep.25912)
72. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E et al. 2010 Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation Research 107 810-817. (doi:10.1161/CIRCRESAHA.110.226357)
73. Zhang Y, Ru Huang X, Wei LH, Chung AC, Yu CM & Lan HY 2014 miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-b/Smad3 signaling. Molecular Therapy 22 974-985. (doi:10.1038/mt.2014.25)
74. Zhao C, Dong J, Jiang T, Shi Z, Yu B, Zhu Y, Chen D, Xu J, Huo R, Dai J et al. 2011 Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS ONE 6 e23925. (doi:10.1371/journal. pone.0023925)
75. Zhao X, Mohan R, Ozcan S & Tang X 2012 MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic b-cells. Journal of Biological Chemistry 287 31155-31164. (doi:10.1074/jbc. M112.362632)
76. Zhong X, Chung AC, Chen HY, Dong Y, Meng XM, Li R, Yang W, Hou FF & Lan HY 2013 miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56 663-674. (doi:10.1007/s00125-012-2804-x)
77. Zhou B, Li C, Qi W, Zhang Y, Zhang F, Wu JX, Hu YN, Wu DM, Liu Y, Yan TT et al. 2012 Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity. Diabetologia 55 2032-2043. (doi:10.1007/s00125-012-2539-8)
78. Zhu H, Shyh-Chang N, Segre AV, Shinoda G, Shah SP, Einhorn WS, Takeuchi A, Engreitz JM, Hagan JP, Kharas MG et al. 2011 The Lin28/let-7 axis regulates glucose metabolism. Cell 147 81-94. (doi:10.1016/j.cell.2011.08.033)